These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1791971

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329.
    Hill DR, Shaw TM, Graham W, Woodruff GN.
    J Neurosci; 1990 Apr; 10(4):1070-81. PubMed ID: 2329368
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK, Milkowski NA, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):235-41. PubMed ID: 7493614
    [Abstract] [Full Text] [Related]

  • 7. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study.
    Morency MA, Quirion R, Mishra RK.
    Neuroscience; 1994 Sep 24; 62(1):307-16. PubMed ID: 7816208
    [Abstract] [Full Text] [Related]

  • 8. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA, Rothblat DS, Joyce JN, Schneider JS.
    Synapse; 1995 Jan 24; 19(1):46-55. PubMed ID: 7709343
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
    Hill DR, Woodruff GN.
    Brain Res; 1990 Sep 03; 526(2):276-83. PubMed ID: 2257485
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E, Stephenson JD, Meldrum BS.
    Eur J Pharmacol; 1991 Sep 24; 202(3):385-90. PubMed ID: 1748160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

  • 18. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
    Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR.
    Brain Res; 1990 Oct 29; 531(1-2):95-104. PubMed ID: 2289139
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.